1. Introduction {#sec1-molecules-24-02934}
===============

The *Zinnia* genus, belonging to the Asteraceae family, is comprised of species grown worldwide for their ornamental role. Such species are very popular especially in North America, the origin of the genus, the center of its diversity being placed in Mexico \[[@B1-molecules-24-02934],[@B2-molecules-24-02934]\]. *Zinnia elegans* (syn. *Z. violacea*), also known as elegant or common zinnia, is the most known and cultivated plant of this genus and was introduced in Europe around 1790, when it started gaining popularity as a garden plant \[[@B1-molecules-24-02934],[@B3-molecules-24-02934]\].

Given its main use as an ornamental plant, very few studies focus on the analysis of secondary metabolites found in the plant in correlation with the plant's therapeutic potential. Some investigations revealed the presence of several classes of natural compounds in certain organs of the plant. Studies of alcoholic extracts obtained from the whole plant or from leaves revealed the presence of saponins, flavonoids, polyphenols, steroids, and glycosides \[[@B4-molecules-24-02934],[@B5-molecules-24-02934]\].

Some species of the Zinnia genus have been studied for their potential biological actions, such as antifungal \[[@B4-molecules-24-02934]\], antioxidant, hepatoprotective \[[@B5-molecules-24-02934]\], antibacterial, antiviral \[[@B6-molecules-24-02934],[@B7-molecules-24-02934]\], antimalarial \[[@B8-molecules-24-02934]\], cytotoxic (demonstrated on cancer cell lines) \[[@B9-molecules-24-02934]\], and insecticidal \[[@B10-molecules-24-02934]\]. However, there are few studies regarding the biological actions of extracts obtained from *Z. elegans* or of its purified compounds. Among these, research regarding the antioxidant, hepatoprotective, antifungal, and antimalarial activities can be found in the literature \[[@B4-molecules-24-02934],[@B5-molecules-24-02934],[@B8-molecules-24-02934]\]. One of our previous studies has revealed that the methanolic extract contains important quantities of flavonoids and presents better antioxidant activity than other extracts obtained using more lipophilic solvents such as chloroform or hexane, suggesting that responsible for this type of activity are polyphenols \[[@B11-molecules-24-02934]\].

Taking into consideration the constant need to discover new plants and implicitly new sources of secondary metabolites with therapeutic potential that could be used in the treatment of inflammatory diseases and cancer \[[@B12-molecules-24-02934]\], we focused our attention on an ornamental plant which has been widely cultivated and in which certain classes of compounds such as polyphenols have already been identified, a fact that might suggest the existence of a therapeutic potential. Moreover, ethnopharmacological data regarding the plant in question provides the example of application of an infusion used for the treatment of pain \[[@B13-molecules-24-02934]\]. Therefore, this study aimed to conduct a phytochemical characterization of the methanolic extract obtained from *Z. elegans* inflorescences and its fractions, as well as to evaluate the antioxidant activity through two different mechanisms (inhibition of lipoxygenase and iron chelation).

2. Results {#sec2-molecules-24-02934}
==========

2.1. Identification of the Constituents Found in the Z. elegans Extract {#sec2dot1-molecules-24-02934}
-----------------------------------------------------------------------

Initial chromatographic analyses of the methanolic extract obtained from *Z. elegans* Jacq. inflorescences indicate the presence of several peaks, most of them tentatively identified as polyphenolic derivatives ([Figure 1](#molecules-24-02934-f001){ref-type="fig"} and [Table 1](#molecules-24-02934-t001){ref-type="table"}, peak numbers assigned based on the retention time). Over 50 compounds were tentatively identified with the help of accurate mass measurements, fragmentation patterns, retention times, UV-Vis (UltraViolet--Visible) spectra, and using the existing literature. A multistep purification procedure led to the isolation of some compounds, which were further analyzed using high-resolution mass spectrometry, one-dimensional ^1^H-, and ^13^C-NMR (Nuclear Magnetic Resonance) spectroscopy. Based on these results, we identified one new compound and a series of other metabolites already described in the literature, out of which one guanidine alkaloid (plantagoguanidinic acid) is presently reported for the first time in *Z. elegans* ([Figure 2](#molecules-24-02934-f002){ref-type="fig"}).

After further purification of the initial methanolic extract using different techniques such as solid phase extraction and LH-20 column chromatography, five fractions were obtained. The first fraction contains as main components two guanidine alkaloids (plumbagine B and plantagoguanidinic acid), while fraction 2 contains mostly monoacylchlorogenic acids such as 3-CQA, 5-CQA, 4-CQA, 3- and 5-pCoQA and also flavonoids such as kaempferol 3-*O*-β-glucopyranosyl-(1→2)\]-β-glucuronopyranoside and kaempferol 3-*O*-pentoside-7-*O*-hexuronide. Fraction 3 generally contains caffeic acid, clovamide, kaempferol 3-*O*-(pentosyl-hexuronide), kaempferol 3-*O*-pentoside-7-*O*-hexuronide, resokaempferol 3-*O*-hexoside, and apigenin 7-*O*-dihexoside. Fraction 4 contains quercetin 3-*O*-hexoside, diacylchlorogenic acids such as 1,5- and 3,5-diCQA, resokaempferol 3-*O*-hexoside and apigenin 7-*O*-(malonyl-hexoside), while the last fraction (Fr 5) contains diacylchlorogenic acids, kaempferol-3-*O*-(malonyl-hexoside), kaempferol-3-*O*-hexoside, and apigenin. Compounds identified in the initial methanolic extract can be found in one or more fractions, as can be seen in [Table 1](#molecules-24-02934-t001){ref-type="table"}.

2.2. Structural Characterization of the New Compounds {#sec2dot2-molecules-24-02934}
-----------------------------------------------------

The multistep chromatographic separation of the initial methanolic extract of *Z. elegans* flowers led to the isolation and ^1^H- and ^13^C-NMR characterization of one new kaempferol 3-*O*-glycoside (**22**) ([Figure 3](#molecules-24-02934-f003){ref-type="fig"}). Moreover, we report the presence in *Z. elegans* of one known, but rarely described guanidine alkaloid-plantagoguanidinic acid (**24**).

Compound **22** was isolated as a yellow amorphous solid with its UV spectrum presenting absorption at 265 nm (Band II) and 345 nm (Band I) \[[@B26-molecules-24-02934]\]. The negative- and positive-ion HR-QTOF-ESI-MS spectra of **22** showed protonated and deprotonated molecule at *m*/*z* 625.1388 and *m*/*z* 623.1266, respectively. On this basis, its molecular formula was determined as C~27~H~28~O~17~. The MS/MS spectra obtained in the negative and positive ionization mode provided structural information about the type of aglycone and sequence of sugars in the oligosaccharide moiety. Namely, ion peak at *m/z* 623.1266 \[M − H\]^−^ gave fragment ions at *m*/*z* 285.0405 \[Aglycone − H\]^−^ (−338 u = C~12~H~18~O~11~ = HexA-Hex), and series of fragments belonging to kaempferol moiety at *m*/*z* 257.0455 \[Aglycone − CO − H\]^−^, 241.0506 \[Aglycone − CO~2~ − H\]^−^, 229.0506 \[Aglycone − C~2~O~2~-H\]^-^, 213.0557 \[Aglycone − C~2~O~3~ − H\]^-^ and 185.0608 \[Aglycone − C~3~O~4~ − H\]^−^ \[[@B25-molecules-24-02934]\]. In the MS/MS spectrum of ion peak at *m*/*z* 625.1388 \[M + H\]^+^ the following fragment ions were observed: *m*/*z* 463.0870 \[M − C~6~H~10~O~5~ + H\]^+^ and *m*/*z* 287.0547 \[M − C~12~H~18~O~11~ + H\]^+^ corresponding to the kaempferol Y~0~^+^ ion, thus suggesting the 3-*O*-glycosylation of kaempferol with a disaccharide sugar chain consisting a linked hexose-hexuronic acid \[[@B27-molecules-24-02934]\]. The analysis of ^13^C-NMR spectra of **22** showed 27 signals, sorted by the Distortionless Enhancement by Polarization Transfer with retention of Quaternaries (DEPTQ) and Heteronuclear Single Quantum Coherence (HSQC) experiments into 1 CH~2~, 16 CH and ten quaternary carbons. The aromatic region of ^1^H-NMR and 2D-COSY (COrrelation SpectroscopY) spectra of compound **22** exhibited the presence of two sets of protons due to flavonol-type aglycon. One set was attributable to a tetra-substituted aromatic ring with two *meta*-coupled protons and appeared at δ~H~ 6.39 (1H, d, *J* = 2.0 Hz, H-8) and 6.20 (1H, d, *J* = 2.0 Hz, H-6) which correlated in the HSQC spectrum with carbon atoms at δ~C~ 94.8 (C-8) and 99.9 (C-6) ([Table 2](#molecules-24-02934-t002){ref-type="table"}.). The other set corresponded to the *para*-substituted aromatic group at δ~H~ 8.02 (1H, d, *J* = 8.5 Hz, H-2′/H-6′) and δ~H~ 6.90 (1H, d, *J* = 8.5 Hz, H-3′/H-5′), following AA'XX' system of ring B of the aglycon. The assignments of remaining carbons of the flavonol moiety were completed by interpretation of the HMBC (Heteronuclear Multiple Bond Coherence) spectra--long-range correlations from H-2′/H-6′ to C-2 (δ 159.0) and C-4′ (δ 161.5), correlation from H-6/H-8 to C-7 (δ 165.9) and C-10 (δ 105.8), from H-6 to C-4 (δ 179.4) and C-5 (δ 163.1) and from H-8 to C-9 (δ 158.5). The carbohydrate region of ^1^H-NMR spectrum displayed the presence of two anomeric proton signals at δ~H~ 5.56 (1H, d, [J]{.ul} = 7.4 Hz, H-1′') and 4.75 (1H, d, *J* = 7.3 Hz, H-1′′′), indicating the presence of two sugar units. These units were elucidated as β-glucuronopyranoside δ~H/C~ 5.56 (H-1′')/101.1 (C-1′') and β-glucopyranoside δ~H/C~ 4.75 (H-1′'')/104.6 (C-1′'') based on the values of ^1^H-^1^H and ^1^J~HC~ coupling constants, and the analysis of 1D TOCSY (Total Correlation Spectroscopy) and 1D ROESY (Rotating frame nuclear Overhauser Effect SpectroscopY), HSQC, F2-coupled HSQC \[[@B28-molecules-24-02934]\] and HMBC. The α/β-orientation of anomeric protons evidenced by the large (\~7 Hz) vicinal ^1^H-^1^H coupling constants and measurements of direct ^1^H-^13^C ^1^*J* coupling constants, with values of \~170 and \~160 Hz \[[@B29-molecules-24-02934]\], respectively, measured in F2-coupled HSQC experiment. The unusually high value of ^1^*J*~HC~ for β-GlcA was an indicator that this moiety was attached to the C-3 (δ 134.7) of the aglycon \[[@B30-molecules-24-02934]\] and it was confirmed by the long-range correlation visible in the HMBC spectrum between H-1′' and C-3. The ^3^J~HC~ correlation observed in the HMBC spectrum between anomeric proton of the glucose H-1′′′ and C-2′' (δ 81.9), together with the NOE effect detected in the 1D ROESY experiment between H-1′′′ and H-2′' (δ 3.81) indicated the presence of 1′′′→ 2′' interglycosidic linkage. Hence, compound **22** was identified as kaempferol 3-*O*-\[β-glucopyranosyl-(1→2)-β-glucuronopyranoside\].

2.3. Antioxidant Activity {#sec2dot3-molecules-24-02934}
-------------------------

The antioxidant activity of the fractions obtained from the methanolic extract of *Z. elegans* inflorescences was determined using two well-known methods: 15-LOX inhibition assay and the iron-chelating activity test. The ability of the tested samples to chelate iron ions, as well as the capacity to inhibit lipoxygenase were expressed using EC~50~ and IC~50~ values ([Table 3](#molecules-24-02934-t003){ref-type="table"}). The results were also compared to the values obtained for the positive controls (kaempferol and ethylenediaminetetraacetic acid---EDTA, respectively), in order to assess their efficiency.

Regarding the lipoxygenase inhibition activity, fraction 2, which contains as one of the most abundant compounds a kaempferol glycoside, presented the most promising activity (18.98 ± 0.22 μg/mL final solution), similar to that of the positive control (kaempferol). Other fractions such as Fr 3 and Fr 4 also presented a good inhibitory activity of the enzyme, while Fr 5, containing less polar compounds than the previous fractions, presented similar activity to that of the initial methanolic extract. Generally, the obtained fractions presented better IC~50~ values for the lipoxygenase inhibition assay than the total extract. On the other hand, the iron-chelating activity was most promising for the initial extract (0.615 ± 0.001 mg/mL final solution) rather than for its selective fractions. However, the calculated value was 10 times higher than that obtained for EDTA, a well-known metal chelator, implying the existence of a lower antioxidant effect explained through this mechanism. Fr 1 had the lowest EC~50~ value (0.714 ± 0.001 mg/mL final solution) out of the tested fractions.

3. Discussion {#sec3-molecules-24-02934}
=============

Several classes of natural metabolites have been previously identified in *Z. elegans*. Among the flavonoids previously identified in the plant were apigenin 7-*O*-glucoside, apigenin 4′-*O*-glucoside, kaempferol 3-*O*-glucoside, kaempferol 3-*O*-xyloside-7-*O*-glucoside, luteolin 7-*O*-glucoside, and quercetin 3-*O*-glucoside \[[@B6-molecules-24-02934],[@B31-molecules-24-02934]\]. Moreover, acetylated cyanidin and pelargonidin diglucosides have also been reported in the inflorescences of *Z. elegans* \[[@B6-molecules-24-02934],[@B32-molecules-24-02934]\].

Another class of metabolites confirmed for the species in question is that of terpenoids, which can be found in the volatile oil, as well as in certain organic extracts. Sesquiterpenes such as ziniolide, germacren D, zinaflorin III and other related compounds have been identified in extracts obtained from the aerial parts or roots \[[@B6-molecules-24-02934],[@B33-molecules-24-02934]\]. The volatile oil obtained from inflorescences presented germacren D and *p*-cymene as major constituents \[[@B34-molecules-24-02934]\].

A screening of new plants containing oil with potential industrial applications revealed that the seeds harvested from the plant contain an important amount of oil (28%) \[[@B35-molecules-24-02934]\]. The content of saturated fatty acids was found to be 29%, while monounsaturated fatty acids were present in a higher proportion (48%) \[[@B35-molecules-24-02934],[@B36-molecules-24-02934]\]. Moreover, *Z. elegans* was also reported to contain acetylenic compounds \[[@B37-molecules-24-02934]\], as well as nicotine-derived alkaloids \[[@B38-molecules-24-02934]\].

In a recent study focusing on the analysis of secondary metabolites found in an ethanolic extract of *Z. elegans* and its fractions through LC-MS techniques, two coumarins (esculetin and umbelliferone), two sesquiterpene lactones (zaluzanin C and 8β-(angeloyloxy)-1β-hydroxyarbusculin B), and some phenylethanoids such as acteoside were identified \[[@B8-molecules-24-02934]\].

The present chemical analysis of the methanolic extract revealed the presence of numerous polyphenolic compounds such as monoacyl- and diacylchlorogenic acids and glycosides of kaempferol, apigenin, quercetin, and resokaempferol, as well as of several amino acids and guanidine alkaloids. To the best of our knowledge, plantagoguanidinic acid (isolated from Fr 1) and kaempferol 3-*O*-\[β-glucopyranosyl-(1→2)-β-glucuronopyranoside\] (isolated from Fr 2) have not been previously reported in *Z. elegans* extracts. Moreover, the latter kaempferol glycoside is being described for the first time in literature in the present work.

The five LH-20 fractions (Fr 1--5) obtained after the purification of the 85% MeOH fraction contain mostly polyphenolic compounds, except for the first fraction containing mostly guanidine alkaloids. It can be observed that starting with Fr 1, the polarity of the eluted compounds starts to decrease. Therefore, the last fraction contains more nonpolar compounds such as apigenin, while the middle fractions contain mostly flavonoid glycosides. As expected, flavonoids containing more sugar moieties were some of the first eluted compounds, while flavonoids with only one sugar group and aglycons can be found towards the end of the separation.

Recently, more and more research regarding the antioxidant activity of medicinal plants has been conducted to discover new plant metabolites that could be used in the treatment of diseases associated with oxidative processes and inflammation, such as cancer and cardiovascular diseases \[[@B39-molecules-24-02934],[@B40-molecules-24-02934]\]. Probably the most important and widespread class of natural antioxidants are polyphenols. Compounds from this class are utilized for their potential beneficial effects in the prevention of various diseases \[[@B41-molecules-24-02934]\]. Several mechanisms of action can explain the antioxidant activity of polyphenolic compounds, but the most common ones are the radical scavenging activity, metal chelation, and inhibition of enzymes involved in the production of free radicals \[[@B41-molecules-24-02934],[@B42-molecules-24-02934]\].

The current study correlates the presence of certain polyphenols such as polycarboxylic acids and flavonoids from *Z. elegans* inflorescences to the antioxidant activity observed through pro-inflammatory enzyme inhibition and metal chelation mechanisms.

Lipoxygenases are a family of enzymes involved in the oxidation of polyunsaturated fatty acids and have different physiological roles, as well as implications in several pathological processes \[[@B43-molecules-24-02934]\]. 15-LOX, one of the enzymes belonging to this group, has recently attracted attention due to its connection to largely spread diseases such as cancer, Alzheimer's disease, and diabetes, a fact that has led to the set-up of a new study direction involving the research for the discovery of new potent 15-LOX inhibitors \[[@B44-molecules-24-02934]\]. Previous studies have shown that polyphenols can act as LOX inhibitors and are responsible for the protective effect against inflammation and oxidation \[[@B45-molecules-24-02934],[@B46-molecules-24-02934]\]. Our results suggest that such compounds have good antioxidant and anti-inflammatory activities given the observed inhibition of the enzyme. It can be noted that purified fractions (Fr 2--4) containing polyphenols such as chlorogenic acids and kaempferol, apigenin and quercetin glycosides present a better inhibitory activity than the total extract, which suggests that other compounds present in it might reduce its ability to inhibit the enzyme. Therefore, the obtained values also indicate that certain polyphenol-rich fractions can present improved antioxidant and anti-inflammatory activities compared to the crude extracts, which justifies the current trend in pharmacognostic research regarding the importance of separation and purification of compounds from total extracts.

Biochemical reactions leading to the production of reactive oxygen species (ROS) are dependent on the presence of several metal ions, such as iron and copper, that act as catalyzers or are directly involved in ROS synthesis \[[@B47-molecules-24-02934],[@B48-molecules-24-02934]\]. Under certain conditions, higher production of ROS can generate oxidative stress, leading to the deterioration of several cell structures and modification of certain substances (e.g., nucleic acids), with severe consequences for hemostasis. Therefore, the chelation of such reduced metals leads to a reduction in the formation of ROS by lowering the available amount of catalyst. This represents one of the possible mechanisms through which substances with certain functional groups such as hydroxyl, carbonyl, and amino can act as antioxidant molecules \[[@B48-molecules-24-02934]\].

The results regarding the metal chelation assay are rather different from the ones obtained for the LOX inhibition, suggesting that the total extract has a better capacity of chelating iron ions than the more purified fractions. Although flavonoids such as kaempferol and quercetin are known as good metal chelators, the values could be explained by the presence of more polyphenolic compounds (e.g., tannins), and implicitly, more hydroxyl groups in the initial extract that can block iron ions \[[@B48-molecules-24-02934],[@B49-molecules-24-02934],[@B50-molecules-24-02934]\]. Fr 1, which contains mostly alkaloids such as plantagoguanidinic acid, appears to have the best metal-chelating activity out of the tested fractions. Although polyphenols are the most tested compounds for their metal-chelating activity, it has also been demonstrated that other compounds such as alkaloids presenting at least a free nitrogen atom also exhibit iron-binding capacity \[[@B51-molecules-24-02934]\]. However, Fr 1 presented one of the highest IC~50~ in the lipoxygenase inhibition assay, which implies a rather weak antioxidant activity. Nevertheless, lipoxygenase inhibition is a more complex process, involving different mechanisms and compounds with such inhibitory properties can either act upon the active site of the enzyme by reducing the ferric ion to its ferrous form, by blocking the ferrous form, or they can alter its tridimensional structure, consequently reducing or blocking its activity \[[@B52-molecules-24-02934]\]. Therefore, the existence of possible synergistic effects of plant constituents could explain why sometimes plant extracts are more active than a specific natural compound.

4. Materials and Methods {#sec4-molecules-24-02934}
========================

4.1. Chemicals and Reagents {#sec4dot1-molecules-24-02934}
---------------------------

LC-MS grade acetonitrile and HPLC grade methanol were purchased from Merck (Darmstadt, Germany). MS-grade formic acid was purchased from Sigma Aldrich (Steinheim, Germany) and ultrapure water was obtained using a Milli-Q Simplicity 185 water purification system (Millipore, Milford, MA, USA). For biochemical tests, lipoxidase from *Glycine max* (soybean) type I-B, as well as linoleic acid, kaempferol (analytical grade) and EDTA were purchased from Sigma Aldrich (Steinheim, Germany), while the acetate buffer 0.1 M pH = 5.25 was prepared by mixing sodium acetate 0.1 M solution with acetic acid (Sigma Aldrich) until the appropriate value of pH was obtained. Similarly, borate buffer (pH 9) was obtained by mixing boric acid (Sigma Aldrich) with NaOH 1 N until the appropriate value of pH was reached. Moreover, the ferrous sulfate solution in 0.2 M hydrochloric acid and the 5 mM ferrozine solution were also obtained by dissolution using the appropriate chemicals and reagents acquired from Sigma Aldrich (Steinheim, Germany).

4.2. Plant Material {#sec4dot2-molecules-24-02934}
-------------------

*Zinnia elegans* cv. Caroussel was cultivated in ecological conditions in the north-eastern part of Romania in the year 2017. Inflorescences were harvested and kept in the Pharmacognosy department of *Grigore T. Popa* University of Medicine and Pharmacy Iași, being assigned the voucher specimen code Zf 2017. The inflorescences were ground using a commercial blender. Ten grams of the obtained powder was weighed, and afterward 200 mL of methanol was added. The extraction was conducted using a magnetic stirrer (DLAB MS-M-S10, Beijing, China) for 3 hours at room temperature. The extract was then filtered through filter paper, and the solvent was evaporated to dryness in a rotary evaporator (150 mbar pressure, temperature 40 °C). The obtained extract was stored at 4 °C until further use.

4.3. Isolation {#sec4dot3-molecules-24-02934}
--------------

The crude methanol extract was purified with the help of various chromatographic methods. Firstly, the extract was subjected to solid phase extraction using a preconditioned RP-C~18~ column (100 × 80 mm i.d.; Cosmosil 140C~18~-PREP, 140 µm), followed by removal of compounds with high polarity (1% MeOH *v*/*v*, 50% MeOH *v*/*v*), while a phenolic-rich fraction was eluted with a solution containing 85% methanol and 0.1% formic acid.

The 85% methanol fraction was further purified on a Sephadex LH-20 (Sigma-Aldrich, Steinheim, Germany) column (970 × 34 mm i.d.) and eluted with MeOH 100%. As a result of this separation, 5 fractions (Fr 1--5) were collected. The composition of the fractions was monitored by LC-MS techniques. After further purification using a semi-preparative HPLC chromatographic system, two compounds that have not been previously reported in *Z. elegans* were obtained from fractions Fr 1 and Fr 2, respectively.

4.4. Semi-Preparative HPLC {#sec4dot4-molecules-24-02934}
--------------------------

Further purification of two LH-20 fractions involved the use of a semi-preparative HPLC Gilson chromatographic system (Gilson Inc., Middleton, WI, USA), equipped with an evaporative light scattering detector (ESLD, Gilson PrepELS II). This purification step was achieved using a RP-C~18~ Kromasil 100-5-C18 column (250 × 10 mm i.d.; 5 µm). The separation was carried out in gradient mode, using aqueous acetonitrile solution (10--60% *v*/*v*), containing 0.1% formic acid. The column was maintained at 40 °C, and the mobile phase flow rate was 4 mL/min.

4.5. High-Resolution LC-MS and Qualitative Analysis {#sec4dot5-molecules-24-02934}
---------------------------------------------------

The crude methanolic extract, as well as LH-20 fractions, were subjected to high-resolution LC-MS analyses. Chromatographic separations were carried out using Thermo Scientific Ultimate 3000RS chromatographic system on a Waters BEH C18 column (150 × 2.1 mm i.d.; 1.7 µm, Milford, USA) held at 50 °C. The separation of the compounds of interest was achieved using concave-shaped gradient (Dionex gradient curve nr. 6) from 5% to 60% of phase B (acetonitrile containing 0.1% formic acid) in phase A (0.1% formic acid in distilled water) over 25 min. The flow rate was 0.55 mL/min. Between the injections, the column was equilibrated with ten volumes of 5% phase B.

The column effluent passed through the flow cell of photodiode array detector, recording absorbances in the 200--600 nm wavelength range with 5 nm bandwidth and 10 Hz acquisition frequency. A flow splitter was then used to divert the column effluent in 1:3 proportion between Q-TOF MS (Bruker Impact II HD, Bruker, Billerica, MA, USA) and charged aerosol detector (CAD, Thermo Corona Veo RS) connected in parallel. CAD acquisition frequency was 10 Hz.

The mass spectrometric analyses were carried out in both positive and negative ion mode with electrospray ionization. Linear (centroid) spectra were acquired over a mass range from *m/z* 50 to *m/z* 2000 at 5 Hz acquisition frequency with the following parameters of mass spectrometer: positive ion capillary voltage 4.5 kV; negative ion capillary voltage 3.0 kV, dry gas flow 6 L/min; dry gas temperature 200° C; nebulizer pressure 0.7 bar; collision cell transfer time 90 μs; prepulse storage 7.0 μs. In each scan, two precursor ions with intensities of over 2000 counts were fragmented. The collision energy was set automatically depending on the *m*/*z* of fragmented ion, in the range of 5 to 100 eV. Acquired data were calibrated internally with sodium formate introduced into the ion source via a 20 µL loop at the beginning of each separation. Data acquisition and processing was performed using Bruker DataAnalysis 4.3 software.

4.6. NMR Spectroscopy {#sec4dot6-molecules-24-02934}
---------------------

The 1D- and 2D-NMR spectra (^1^H, ^13^C DEPTQ, ^1^H-^13^C HSQC, ^1^H-^13^C H2BC, ^1^H-^13^C HMBC, ^1^H-^13^C F2-coupled HSQC, ^1^H-^1^H COSY, 1D-TOCSY, 1D-ROESY) were acquired using an Avance III HD Ascend 500 MHz spectrometer (Bruker BioSpin, Rheinstetten, Germany), in MeOH-*d~4~* with 0.1% of trifluoroacetic acid at 30 °C.

### Characteristic Data of Isolated Z. elegans Compounds

Kaempferol 3-*O*-\[β-glucopyranosyl-(1→2)-β-glucuronopyranoside\] (**22**); yellow amorphous solid; UV (PDA, MeCN/H~2~O) λ~max~ (nm) 265, 345; HR-QTOF-MS (neg.) *m/z* 623.1266 \[M − H\]^−^ (calc. for C~27~H~27~O~17~ 623.1254). ^1^H- and ^13^C-NMR spectroscopic data ([Table 2](#molecules-24-02934-t002){ref-type="table"}).

Plantagoguanidinic acid (**24**); colorless oil; HR-QTOF-MS (neg.) *m*/*z* 224.1408 \[M − H\]^−^ (calc. for C~11~H~18~N~3~O~2~ 224.1405). ^13^C-NMR (125 MHz, MeOH-*d~4~*) δ 181.0 (C-1), 161.3 (C-2′), 133.2 (C-6), 124.9 (C-5), 58.5 (C-4′), 53.0 (C-2), 48.0 (C-5′), 30.0 (C-3), 26.9 (C-4), 25.9 (C-8), 17.8 (C-7); ^1^H-NMR (500 MHz, MeOH-*d~4~*) δ 2.45 (1H, m, H-2), 1.64 (1H, m, H-3a), 1.57 (1H, m, H-3b), 2.27 (1H, m, H-4a), 2.10 (1H, m, H-4b), 5.14 (1H, t, *J* = 6.9 Hz, H-5), 1.61 (3H, s, H-7), 1.68 (3H, s, H-8), 4.16 (1H, m, H-4′), 3.76 (1H, t, *J* = 9.5 Hz, H-5′a), 3.54 (1H, m, H-5′b).

^1^H- and ^13^C-NMR spectra of these compounds are available in the [Supplementary Materials](#app1-molecules-24-02934){ref-type="app"}.

4.7. Antioxidant Tests {#sec4dot7-molecules-24-02934}
----------------------

### 4.7.1. Lipoxygenase Inhibition {#sec4dot7dot1-molecules-24-02934}

The lipoxygenase inhibition activity was evaluated using the amended Malterud method \[[@B53-molecules-24-02934]\]. 0.05 mL of lipoxidase from *Glycine max* (soybean) in borate buffer (pH 9) was mixed with the same volume of the sample solution in DMSO (in various concentrations). After 10 minutes, 2 mL of 0.16 mM linoleic acid borate buffer were added and the absorbances were registered at 234 nm for 90 seconds. The inhibition of lipoxygenase was established using the following formula: % inhibition = (A~EFI~ − A~ECI~) × 100/A~EFI~; A~EFI~ is the difference of the enzyme absorbance without inhibitor at 90 and 30 seconds, while A~ECI~ represents the same difference of the enzyme-inhibitor mixture. Kaempferol was used as positive control and the IC~50~ values were calculated for each sample and expressed as µg/mL. All experiments were performed in triplicate.

### 4.7.2. Metal Chelation {#sec4dot7dot2-molecules-24-02934}

The potential to chelate ferrous ions was determined for the investigated extracts according to the method described by Venditti et al. with some modifications \[[@B54-molecules-24-02934],[@B55-molecules-24-02934]\]. The ferrous ions form with ferrozine a complex with maximum absorbance at 562 nm. Consequently, the presence of a chelating agent in the reaction medium decreases the absorbance of the complex. 0.2 mL sample solution, 0.74 mL 0.1 M acetate buffer (pH 5.25) and 0.02 mL 2 mM ferrous sulphate solution in 0.2 M hydrochloric acid were mixed. After 10--15 s, 0.04 mL of 5 mM ferrozine solution was added. The absorbance of the solution was determined after being kept for 10 min in the dark, against a blank prepared under similar conditions. The metal chelating activity was determined using the following formula: Activity % = 100 × (Ac − Ap)/(Ac), where Ac is the absorbance of the control solution and Ap is the absorbance of the sample solution. EDTA was used as positive control. The EC~50~ was calculated for each extract and expressed as mg sample/mL final solution. The assay was carried out in triplicate.

### 4.7.3. Statistical Analysis {#sec4dot7dot3-molecules-24-02934}

The one-way ANOVA followed by Tukey's honest significant difference test was performed using freely available web-based online software <https://houssein-assaad.shinyapps.io/SumAOV/> \[[@B56-molecules-24-02934]\]. The chosen level of significance was *p* \< 0.05. Data are expressed as means ± standard deviation.

5. Conclusions {#sec5-molecules-24-02934}
==============

This study focused on a phytochemical HR LC-MS analysis of a methanolic extract obtained from *Z. elegans* inflorescences, in which more than 50 compounds from different classes, such as polyphenols and alkaloids, were identified. After further separations, five fractions were chemically characterized and tested for potential antioxidant activities. Fractions Fr 2 with a rich content in monoacylchlorogenic acids and flavonoid glycosides and Fr 1, having alkaloids as major constituents, showed promising results. Therefore, these two fractions were subjected to additional purification, and two compounds (plantagoguanidinic acid and a new kaempferol glycoside), which have not been previously reported in *Z. elegans,* were isolated and characterized using NMR techniques. In conclusion, this paper is part of current scientific trends; namely, the discovery of new sources of natural metabolites with biological actions and the isolation of such compounds for potential therapeutic applications.
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![UHPLC-CAD profile of the *Z. elegans* methanolic extract.](molecules-24-02934-g001){#molecules-24-02934-f001}

![General structures and substitution patterns of phenolic acids, flavonoids, and alkaloids found in *Z*. *elegans* inflorescences.](molecules-24-02934-g002){#molecules-24-02934-f002}

![Structure of compound (**22**) isolated from the flowers of *Z. elegans* and key HMBC (H→C) and ^1^H-^1^H COSY (---) correlations.](molecules-24-02934-g003){#molecules-24-02934-f003}

molecules-24-02934-t001_Table 1

###### 

Compounds identified in the *Z. elegans* methanolic extract and the obtained fractions using UHPLC-QTOF-MS/MS.

  No.    Compound Name                                                       RT (min)   λ~max~ (nm)   Formula              Error (ppm) \*\*   mσ \*\*\*   Observed \[M − H\]^−^   Major Fragments (%)                                                                                                                                                 Fraction   Reference
  ------ ------------------------------------------------------------------- ---------- ------------- -------------------- ------------------ ----------- ----------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------- ---------------------------------------------------------
  1\.    Quinic acid                                                         0.62       \-            C~7~H~12~O~6~        0.5                1.5         191.0560                173.0450 (2)                                                                                                                                                        1,2        \[[@B14-molecules-24-02934]\]
  2\.    Hexoso(iso)leucine                                                  0.79       \-            C~12~H~23~NO~7~      −0.7               1.4         294.1549 \*             276.1443 (100), 258.1338 (19), 230.1388 (17), 294.1548 (12), 132.1021 (5)                                                                                           1          \[[@B15-molecules-24-02934]\]
  3\.    (Iso)leucine                                                        0.79       \-            C~6~H~13~NO~2~       −0.6               2.8         132.1020 \*             132.1019 (100), 86.0967 (1)                                                                                                                                         1          \[[@B15-molecules-24-02934]\]
  4\.    Phenylalanine                                                       1.24       \-            C~9~H~11~NO~2~       5.3                15.7        164.0708                \-                                                                                                                                                                  1          \[[@B15-molecules-24-02934]\]
  5\.    3-CQA                                                               1.79       250, 325      C~16~H~18~O~9~       −0.1               3.6         353.0878                191.0565 (100), 179.0354 (37), 135.0436 (16)                                                                                                                        1,2        \[[@B16-molecules-24-02934]\]
  6\.    Tryptophan                                                          1.96       280           C~11~H~12~N~2~O~2~   −0.9               9.1         205.0972 \*             188.0708 (100), 146.0603 (26), 144.0811 (6), 205.0974 (6)                                                                                                           1,2        \[[@B15-molecules-24-02934]\]
  7\.    3-*p*CoQA                                                           2.51       310           C~16~H~18~O~8~       −0.4               9.0         337.0930                163.0399 (100), 119.0495 (37), 191.0556 (19)                                                                                                                        1,2        \[[@B16-molecules-24-02934]\]
  8\.    1-*p*CoQA                                                           2.62       305           C~16~H~18~O~8~       −1.0               17.1        337.0932                191.0567 (100), 163.0400 (34), 119.0492 (9)                                                                                                                         1,2        \[[@B16-molecules-24-02934]\]
  9\.    5-CQA                                                               2.78       245, 325      C~16~H~18~O~9~       −0.4               3.4         353.0880                191.0563 (100), 179.0265 (1), 135.0433 (1), 173.0438 (1)                                                                                                            1,2,3      \[[@B16-molecules-24-02934]\]
  10\.   Caffeic acid                                                        2.96       320           C~9~H~8~O~4~         −0.3               1.8         179.0353                135.0441 (100), 179.0359 (42)                                                                                                                                       2,3,4      \[[@B17-molecules-24-02934]\]
  11\.   4-CQA                                                               3.11       325           C~16~H~18~O~9~       −0.7               17.0        353.0880                191.0567 (100), 179.0351 (48), 173.0454 (40), 135.0439 (31)                                                                                                         2,3        \[[@B16-molecules-24-02934]\]
  12\.   Plumbagine B                                                        3.18       \-            C~11~H~17~N~3~O~2~   −0.3               1.1         222.1251                222.1251 (100), 178.1351 (12)                                                                                                                                       1          \[[@B18-molecules-24-02934]\]
  13\.   Plumbagine B - isomer                                               3.77       \-            C~11~H~17~N~3~O~2~   −0.4               6.0         224.1395 \*             \-                                                                                                                                                                  1          \[[@B18-molecules-24-02934]\]
  14\.   5-*p*CoQA epimer                                                    3.92       310           C~16~H~18~O~8~       −2.5               2.0         337.0937                191.0567 (100), 163.0402 (8)                                                                                                                                        1,2        \[[@B16-molecules-24-02934]\]
  15\.   *p*-Coumaric acid                                                   4.32       310           C~9~H~8~O~3~         0.0                3.6         165.0546 \*             147.0441 (100), 119.0491 (11), 165.0543 (9)                                                                                                                         2          \[[@B17-molecules-24-02934]\]
  16\.   Quercetin-3-*O*-(hexosyl-hexuronide)                                5.05       255, 345      C~27~H~28~O~18~      0.8                5.6         641.1343 \*             303.0499 (100), 479.0821 (40), 301.0344 (12)                                                                                                                        2,3,4      \[[@B19-molecules-24-02934]\]
  17\.   Clovamide                                                           5.19       290, 320      C~18~H~17~NO~7~      −1.9               40.4        358.0939                178.0498 (100), 179.0346 (61), 161.0247 (30)                                                                                                                        2,3,4      \[[@B20-molecules-24-02934],[@B21-molecules-24-02934]\]
  18\.   5-*p*CoQA epimer                                                    5.29       300           C~16~H~18~O~8~       −2.6               26.4        337.0938                191.0566 (100)                                                                                                                                                      1,2        \[[@B16-molecules-24-02934]\]
  19\.   Methyl-Plumbagine B                                                 5.52       \-            C~12~H~19~N~3~O~2~   1.9                10.1        238.1550 \*             238.1546 (100), 178.1333 (1), 196.1326 (0.3), 136.1117 (0.2), 110.0959 (0.1)                                                                                        1,2        \[[@B18-molecules-24-02934]\]
  20\.   Quercetin-3-*O*-(pentosyl-hexoside)                                 5.73       265, 350      C~26~H~28~O~16~      −2.0               5.6         595.1316                300.0288 (100), 271.0248 (30)                                                                                                                                       2,3,4      \[[@B21-molecules-24-02934]\]
  21\.   Plantagoguanidinic acid isomer                                      5.87       \-            C~11~H~19~N~3~O~2~   2.2                9.6         226.1550 \*             226.1544 (100), 208.1437 (5), 180.1488 (1), 149.0955 (1)                                                                                                            1          \[[@B18-molecules-24-02934]\]
  22\.   Kaempferol 3-*O*-\[β-glucopyranosyl-(1→2)-β-glucuronopyranoside\]   6.02       265, 345      C~27~H~28~O~17~      −1.9               3.9         623.1266                285.0409 (100), 229.0510 (21), 257.0461 (15), 241.0508 (3)                                                                                                          2,3        \-
  23\.   Kaempferol 3-*O*-(hexosyl-hexoside)                                 6.06       260, 345      C~27~H~30~O~16~      3.4                24.7        611.1586 \*             287.0545 (100), 449.1073 (92), 611.1597 (38), 226.1533 (4)                                                                                                          3          \[[@B22-molecules-24-02934]\]
  24\.   Plantagoguanidinic acid                                             6.26       \-            C~11~H~19~N~3~O~2~   −1.4               5.1         224.1408                141.0913 (100), 224.1404 (44), 180.1510 (32)                                                                                                                        1          \[[@B18-molecules-24-02934]\]
  25\.   Quercetin 3-*O*-hexoside                                            6.56       255, 350      C~21~H~20~O~12~      −1.3               1.9         463.0888                300.0285 (100)                                                                                                                                                      3,4,5      \[[@B23-molecules-24-02934]\]
  26\.   Kaempferol 3-*O*-(pentosyl-hexoside)                                6.87       265, 345      C~26~H~28~O~15~      2.1                14.3        581.1501 \*             287.0542 (100), 449.1067 (9), 163.0601 (1), 145.0495 (1)                                                                                                            2,3,4      \[[@B19-molecules-24-02934]\]
  27\.   Kaempferol 3-*O*-(pentosyl-hexuronide)                              6.87       265, 345      C~26~H~26~O~16~      2.4                19.4        595.1279 \*             287.0546 (100), 463.0866 (42), 273.0748 (12)                                                                                                                        2,3,4      \[[@B19-molecules-24-02934]\]
  28\.   Kaempferol 3-*O*-(pentosyl-hexoside)                                7.02       265, 345      C~26~H~28~O~15~      -1.8               7.5         579.1355                284.0330 (100), 255.0311 (37), 227.0344 (17)                                                                                                                        2,3,4      \[[@B19-molecules-24-02934]\]
  29\.   Kaempferol 3-*O*-pentoside-7-*O*-hexuronide                         7.27       265, 345      C~26~H~26~O~16~      1.0                13.1        595.1288 \*             287.0541 (100), 463.0866 (33), 433.1130 (12), 271.0587 (10)                                                                                                         2,3,4      \[[@B19-molecules-24-02934]\]
  30\.   Kaempferol 3-*O*-hexoside                                           7.27       265, 345      C~21~H~20~O~11~      2.1                3.5         449.1069 \*             287.0545 (100), 449.1060 (15)                                                                                                                                       4,5        \[[@B19-molecules-24-02934]\]
  31\.   Apigenin 7-*O*-dihexoside                                           7.27       265, 345      C~27~H~30~O~15~      −0.7               8.4         593.1516                269.0462 (100)                                                                                                                                                      2,3        \[[@B19-molecules-24-02934]\]
  32\.   Kaempferol 3-*O*-hexoside                                           7.59       260, 335      C~21~H~20~O~11~      −0.9               11.3        447.0937                284.0340 (100), 255.0312 (55)                                                                                                                                       2,3,4,5    \[[@B22-molecules-24-02934]\]
  33\.   Kaempferol-3-*O*-hexuronide                                         8.02       245, 325      C~21~H~18~O~12~      −0.9               13.0        461.0725                285.0409 (100), 229.0502 (22), 257.0458 (10)                                                                                                                        1,2,3,4    \[[@B19-molecules-24-02934]\]
  34\.   1,5-diCQA/3,5-diCQA                                                 8.02       245, 325      C~25~H~24~O~12~      0.1                1.7         515.1195                191.0562 (100), 179.0349 (10), 173.0450 (3)/191.0564 (100), 179.0349 (34), 135.0445 (16)353.0876 (12)                                                               3,4,5      \[[@B16-molecules-24-02934]\]
  35\.   Kaempferol-3-*O*-hexoside                                           8.47       265, 340      C~21~H~20~O~11~      0.1                2.7         447.0932                285.0404 (100), 257.0456 (1), 241.0497 (1)                                                                                                                          2,3,4,5    \[[@B19-molecules-24-02934]\]
  36\.   Resokaempferol 3-*O*-hexoside                                       8.63       265, 335      C~21~H~20~O~10~      0.6                5           431.0981                268.0379 (100)                                                                                                                                                      3,4,5      \[[@B19-molecules-24-02934]\]
  37\.   3,4-diCQA                                                           9.19       325           C~25~H~24~O~12~      0.7                5.8         515.1191                191.0558 (100), 173.0451 (77)                                                                                                                                       3,4,5      \[[@B16-molecules-24-02934]\]
  38\.   Kaempferol-3-*O*-(malonyl-hexoside)                                 9.19       325           C~24~H~22~O~14~      1.1                21.7        535.1076 \*             287.0545 (100), 535.1076 (60), 285.0388 (12), 257.0442 (6), 449.1067 (3)                                                                                            3,4,5      \[[@B19-molecules-24-02934]\]
  39\.   *p*Co,CQA isomer                                                    9.37       320           C~25~H~24~O~11~      1.9                8.6         501.1382 \*             163.0383 (100), 147.0436 (99), 483.1278 (32), 337.0924 (5)                                                                                                          3          \[[@B16-molecules-24-02934]\]
  40\.   C~13~-norisoprenoid hexoside                                        9.68       \-            C~19~H~32~O~7~       2.6                14.9        373.2211 \*             211.1690 (100), 193.1585 (25), 135.1162 (12), 175.1473 (11)                                                                                                         1          \[[@B24-molecules-24-02934]\]
  41\.   Kaempferol 3-*O*-(caffeoyl-pentoside)-7-*O*-hexuronide              9.68       330           C~35~H~32~O~19~      2.4                12.7        757.1592 \*             287.0546 (100), 277.0704 (36), 463.0868 (35), 163.0388 (22), 295.0807 (11)                                                                                          5          \[[@B19-molecules-24-02934]\]
  42\.   Methyl-plantagoguanidinic acid                                      10.11      \-            C~12~H~21~N~3~O~2~   2.2                4.1         240.1701 \*             240.1704 (100), 208.1439 (4), 181.1214 (0.6)                                                                                                                        1          \[[@B18-molecules-24-02934]\]
  43\.   Apigenin 7-*O*-(malonyl-hexoside)                                   10.11      330           C~24~H~22~O~13~      2.0                9.6         519.1123 \*             271.0596 (100), 519.1127 (27)                                                                                                                                       3,4        \[[@B19-molecules-24-02934]\]
  44\.   Kaempferol-3-*O*-(acetyl-hexoside)                                  10.11      330           C~23~H~22~O~12~      1.7                54.6        491.1176 \*             287.0544 (100)                                                                                                                                                      3          \[[@B19-molecules-24-02934]\]
  45\.   Kaempferol-3-*O*-(malonyl-hexoside)                                 10.48      265, 330      C~24~H~22~O~14~      2.0                7.0         535.1072 \*             287.0550 (100), 535.1076 (91)                                                                                                                                       3,4,5      \[[@B19-molecules-24-02934]\]
  46\.   Apigenin 7-*O*-(malonyl-hexoside)                                   10.69      265, 335      C~24~H~22~O~13~      1.3                4.7         519.1126 \*             271.0601 (100), 519.1133 (54)                                                                                                                                       3,4        \[[@B22-molecules-24-02934]\]
  47\.   Apigenin 7-*O*-(malonyl-hexoside)                                   10.87      270, 330      C~24~H~22~O~13~      1.4                3.4         519.1126 \*             519.1129 (100), 271.0599 (93)                                                                                                                                       3,4        \[[@B19-molecules-24-02934]\]
  48\.   Kaempferol 3-*O*-(p-coumaroyl-pentoside)-7-*O*-hexuronide           11.10      265, 320      C~35~H~32~O~18~      1.0                27.3        741.1654 \*             287.0550 (100), 261.0761 (53), 463.0873 (35), 147.0441 (21), 279.0862 (16)                                                                                          3,4        \[[@B19-molecules-24-02934]\]
  49\.   Apigenin                                                            12.82      265, 335      C~15~H~10~O~5~       1.1                0.8         269.0452                225.0559 (6), 117.0326 (2)                                                                                                                                          3,4,5      \[[@B25-molecules-24-02934]\]
  50\.   Di-*p*-coumaroyl-caffeoyl-C~18~H~36~O~6~                            15.31      295, 310      C~45~H~54~O~13~      2.4                23.6        803.3618 \*             147.0441 (100), 657.3271 (44), 163.0388 (27), 641.3336 (14), 275.1751 (13), 204.1017 (11), 511.2924 (11), 495.2958 (10), 119.0490 (8), 291.1697 (6), 655.3094 (5)   2,3        \-
  51\.   Di-*p*-coumaroyl-caffeoyl-C~18~H~36~O~6~                            15.40      295, 310      C~45~H~54~O~13~      1.2                31.6        803.3628 \*             147.0441 (100), 657.3277 (47), 163.0388 (41), 204.1016 (22), 275.1750 (20), 641.3322 (20), 495.2967 (16), 511.2907 (9)                                              2,3        \-
  52\.   Tri-*p*-coumaroyl-C~18~H~36~O~6~                                    16.17      300           C~45~H~54~O~12~      0.9                21.3        787.3681 \*             147.043 (100), 641.3324 (53), 204.1017 (20), 275.1750 (15), 495.2962 (15), 119.0487 (7), 477.2854 (4), 349.2598 (1)                                                 2,3        \-
  53\.   3-O-Methyl-kaempferol                                               16.47      \-            C~16~H~12~O~6~       1.0                8.9         301.0704 \*             301.0704 (100)                                                                                                                                                      5          \[[@B19-molecules-24-02934]\]

\* Measured in positive ESI ionization mode as \[M + H\]^+^. \*\* Mass accuracy measurements expressed in parts per million (ppm). \*\*\* Isotopic pattern fit factor (mσ).

molecules-24-02934-t002_Table 2

###### 

^1^H- and ^13^C-NMR data (MeOH-*d~4~* + 0.1% trifluoroacetic acid, 500/125 MHz, 30 °C) for compound **22**.

  Position.   δ~H~ (*J* in Hz)                         δ~C~, Type
  ----------- ---------------------------------------- -------------
  2                                                    159.0, C
  3                                                    134.7, C
  4                                                    179.4, C
  5                                                    163.1, C
  6           6.20 d (2.0)                             99.9, CH
  7                                                    165.9, C
  8           6.39 d (2.0)                             94.8, CH
  9                                                    158.5, C
  10                                                   105.8, C
  1′                                                   122.7, C
  2′/6′       8.02 d (8.5)                             132.3, CH
  3′/5′       6.90 d (8.5)                             116.3, CH
  4′                                                   161.5, C
  1′'         5.56 d (7.4)                             101.1, CH
  2′'         3.81 dd (9.0, 7.4)                       81.9, CH
  3′'         3.67 t (9.0)                             77.3, CH
  4′'         3.64 t (9.0)                             72.6, CH
  5′'         3.76 d (9.0)                             76.8, CH
  6′'                                                  171.7, C
  1′''        4.75 d (7.3)                             104.6, CH
  2′''        3.35 dd (9.5, 7.3)                       75.5, CH
  3′''        3.38 overlap                             77.9, CH
  4′''        3.37 overlap                             71.3, CH
  5′''        3.28 ddd (8.4, 5.0, 2.2)                 78.2, CH
  6′''        3.78 dd (12.0, 2.2)3.68 dd (12.0, 5.0)   62.6, CH~2~

molecules-24-02934-t003_Table 3

###### 

Antioxidant activities of *Z. elegans* fractions.

                     Lipoxygenase Inhibition   Iron-Chelating Activity
  ------------------ ------------------------- -------------------------
  Fr 1               65.65 ± 0.50 ^a^ \*       0.714 ± 0.001 ^e^
  Fr 2               18.98 ± 0.22 ^d^          1.037 ± 0.003 ^d^
  Fr 3               30.25 ± 0.73 ^c^          1.620 ± 0.006 ^c^
  Fr 4               41.67 ± 1.46 ^b^          1.919 ± 0.011 ^a^
  Fr 5               69.37 ± 6.71 ^a^          1.664 ± 0.011 ^b^
  Initial extract    69.21 ± 0.89 \*\* ^a^     0.615 ± 0.001 ^f^
  Positive control   20.25 ± 0.44 ^d^          0.068 ± 0.003 ^g^

\* Values are the means ± standard deviation, *n* = 3. ^a--g^ Means in a column without a common superscript letter differ (*p* \< 0.05), as indicated by one-way ANOVA. \*\* Data already published \[[@B11-molecules-24-02934]\].

[^1]: These authors contributed equally to this work.
